Status:
RECRUITING
Korean Heart Failure Registry III
Lead Sponsor:
Seoul National University Bundang Hospital
Collaborating Sponsors:
Korean Society of Heart Failure
Conditions:
Acute Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
KorHF III is a multi-center, nationwide, prospective registry of the Korean Society of Heart Failure, which enrolls patients with acute heart failure in Korea. The aim of this registry is to analyze ...
Eligibility Criteria
Inclusion
- All consecutive hospitalized adult heart failure patients who fulfill one of 1-3 and 4
- Symptoms of heart failure
- Signs of heart failure
- Lung congestion in Chest-x-ray
- Objective finding of structural and/or functional disorder of the heart or elevated natriuretic peptide levels
Exclusion
- Patients younger than 18 years old
- Patients who do no consent
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04329234
Start Date
October 1 2018
End Date
December 31 2027
Last Update
April 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam, South Korea, 463707